Akero Therapeutics, Inc.
Industry: Life Sciences ・ $AKRO on Nasdaq
Insider Purchase
+$9,600,000
+24.93%
Shares
Shares Volume: 200,000 Shares
Average Share Price: $48
INSIDER
Graham G. Walmsley
Director
reported on Feb 7 2025
traded on Jan 30 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 1,002,168 |
| PURCHASES/SALES 1Y | 1 / 0 |
| P/S VALUE RATIO | n/a |
| AVERAGE PURCHASE VALUE | $9,600,000 |
| INSIDER PREVIOUS TRADES | No trades in past 1Y |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 1 / 5 |
| PURCHASES/SALES 1Y | 1 / 53 |
| P/S VALUE RATIO | 0.252 |
| AVERAGE PURCHASE VALUE | $9,600,000 |
| COMPANY PREVIOUS TRADES |